4th Rx-to-OTC Switch Summit – 4th Rx-to-OTC Switch Summit

Featured Speakers

Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling, and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC.

Now in its fourth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends, and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests.

New This Year

LEGAL/REGULATORY, ACCESS, AND EMPLOYER/CONSUMER TRENDS THAT CAN IMPACT RX-TO-OTC EXISTING OR FUTURE PRODUCTS

EXPLORE POLICY AND PROGRAM IMPLICATIONS OF A NALOXONE RX-OTC SWITCH

UNDERSTANDING KEY ELEMENTS OF CONSUMER BEHAVIOR STUDIES IN A COMPLEX RX-TO-OTC SWITCH

PARTNERING WITH HRA PHARMA AND MOVING ORAL CONTRACEPTIVES OTC IN THE US

Who Should Attend

This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:

  • Rx-to-OTC Switches
  • Consumer Healthcare Products
  • Marketing/Brand Management/Product Management
  • Regulatory Affairs/Regulatory Processes
  • Clinical Development
  • Legal Affairs/Counsel/Regulatory Counsel
  • Medical/Scientific Affairs
  • Clinical Trials
  • Research and Development
  • Business Strategy
  • Labeling/Packaging
  • Drug Delivery Technology
  • Product Development
  • Corporate Development

This event is also of interest to:

  • Strategy and Marketing Consultants
  • Clinical Research Labs
  • CROs/CMOs
  • Drug After-Market Manufacturers/Suppliers
  • Legal/Regulatory Advisors
  • Statistical Service Providers
  • Marketing Organizations
Startdate: 2017-12-06
End Date 2017-12-07

Description: The 4th Rx-to-OTC Switch Summit is the leading event for pharmaceutical leaders active in over-the-counter drug availability and the switch from Rx to OTC.
Performer: ExL Events
Offer Name:


Price: $
Address : 1800 Market Street 4th Rx-to-OTC Switch Summit
Philadelphia
PA
USA